Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 11846050)

Published in Scand J Rheumatol on January 01, 2001

Authors

N Yeomans1, I Wilson, G Långström, C Hawkey, J Naesdal, A Walan, I Wiklund

Author Affiliations

1: Department of Medicine, The University of Melbourne, Western Hospital, Footscray, Australia. n.yeomans@unimelb.edu.au

Articles by these authors

Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem (2000) 8.76

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16

Development and first validation of the COPD Assessment Test. Eur Respir J (2009) 8.06

Management of proximal femoral fractures 2011: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia (2012) 7.11

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ (1996) 5.80

Coordinated plant defense responses in Arabidopsis revealed by microarray analysis. Proc Natl Acad Sci U S A (2000) 5.52

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology (2000) 5.40

Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet (1978) 3.69

Laparoscopic peritoneal lavage for generalized peritonitis due to perforated diverticulitis. Br J Surg (2008) 3.67

Cimetidine in the treatment of active duodenal and prepyloric ulcers. Lancet (1976) 3.61

Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg (2007) 2.66

Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res (1998) 2.58

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol (1998) 2.44

Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20

A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment. Health Technol Assess (1997) 2.19

Health-related quality of life in patients with adolescent idiopathic scoliosis: a matched follow-up at least 20 years after treatment with brace or surgery. Eur Spine J (2001) 2.19

Community psychiatry: selling skills. Community Outlook (1986) 2.09

The influence of urinary incontinence on the quality of life of elderly women. Age Ageing (1993) 2.07

Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial. The Nordic GORD Study Group. Eur J Gastroenterol Hepatol (2000) 1.81

Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol (1995) 1.79

The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther (2004) 1.76

Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol (1993) 1.75

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol (1999) 1.74

Cross-cultural adaptation of health measures. European Group for Health Management and Quality of Life Assessment. Health Policy (1991) 1.68

Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl (1996) 1.63

The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease. Br J Clin Pharmacol (1979) 1.59

Neutrophil activation by Helicobacter pylori. Gut (1991) 1.59

Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol (2001) 1.57

An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology (2001) 1.57

The influenza hemagglutinin precursor as an acid-sensitive probe of the biosynthetic pathway. EMBO J (1987) 1.54

The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther (2007) 1.53

The feeling of loneliness prior to coronary artery bypass grafting might be a predictor of short-and long-term postoperative mortality. Eur J Vasc Endovasc Surg (1998) 1.53

Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther (2015) 1.51

Addition of carbohydrate side chains at novel sites on influenza virus hemagglutinin can modulate the folding, transport, and activity of the molecule. J Cell Biol (1988) 1.50

High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-associated gastritis, and gastric atrophy. Endoscopy (2007) 1.49

Genealogies and geography. Philos Trans R Soc Lond B Biol Sci (1995) 1.47

A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Scand J Gastroenterol (1987) 1.47

A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol (1986) 1.46

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46

Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease. Scand J Gastroenterol (1984) 1.44

Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis. Osteoporos Int (1997) 1.43

Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs. Structure (1999) 1.42

Why doctors should think more carefully before prescribing. Hosp Med (2001) 1.40

Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation (2000) 1.40

Historical background of antiseptic surgery. Ir Med J (2001) 1.40

Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg (2001) 1.39

Volunteer programme. Br Dent J (2006) 1.38

An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol (2003) 1.34

Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther (2005) 1.32

A critical review of dimension-specific measures of health-related quality of life in cross-cultural research. Qual Life Res (1993) 1.27

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut (2004) 1.24

Recall of informed consent information by healthy volunteers in clinical trials. QJM (2008) 1.24

Education of adult patients at an "asthma school": effects on quality of life, knowledge and need for nursing. Eur Respir J (1990) 1.21

Selective 5-lipoxygenase inhibition in ulcerative colitis. Lancet (1990) 1.21

Determinants of an impaired quality of life five years after coronary artery bypass surgery. Heart (1999) 1.21

Professional identity and nursing: contemporary theoretical developments and future research challenges. Int Nurs Rev (2012) 1.18

Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis. Br J Rheumatol (1998) 1.18

Effect of triac on the developing heart. Lancet (1977) 1.17

The Norwegian version of the Quality of Life Scale (QOLS-N). A validation and reliability study in patients suffering from psoriasis. Scand J Caring Sci (1998) 1.17

The plastid in Plasmodium falciparum asexual blood stages: a three-dimensional ultrastructural analysis. Protist (1999) 1.17

The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study. Arch Biochem Biophys (1988) 1.17

Impact factor of medical education journals and recently developed indices: Can any of them support academic promotion criteria? J Postgrad Med (2016) 1.17

Acupuncture and transcutaneous nerve stimulation in stroke rehabilitation: a randomized, controlled trial. Stroke (2001) 1.14

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol (1993) 1.13

Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther (2001) 1.13

Health-related quality of life in persons with acquired immune deficiency syndrome. Med Care (1993) 1.12

IgA anti-gliadin antibodies and jejunal mucosal lesions in healthy blood donors. Lancet (1986) 1.12

Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter (2000) 1.12

Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial. Gut (1991) 1.11

Comparison of Erysiphe cichoracearum and E. cruciferarum and a survey of 360 Arabidopsis thaliana accessions for resistance to these two powdery mildew pathogens. Mol Plant Microbe Interact (1999) 1.11

Validation of the translation and cross-cultural adaptation into Finnish of the Abdominal Symptom Questionnaire, the Hospital Anxiety and Depression Scale and the Complaint Score Questionnaire. Scand J Gastroenterol (2004) 1.09

Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers. Scand J Gastroenterol (1981) 1.08

High prevalence of potentially virulent strains of Helicobacter pylori in the general male British population. Gut (2000) 1.08

A novel hydrogen sulfide donor causes stomatal opening and reduces nitric oxide accumulation. Plant Physiol Biochem (2010) 1.08

Vagal function in patients with diabetic neuropathy. Acta Med Scand (1972) 1.07

On the prevalence of adult coeliac disease in Sweden. Scand J Gastroenterol (1981) 1.07

Evidence for a Single Origin of the 35 kb Plastid DNA in Apicomplexans. Protist (2009) 1.07

Self-assessment of quality of life in severe heart failure. An instrument for clinical use. Scand J Psychol (1987) 1.07

Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf) (1994) 1.06

Serum folate determinations in tracing adult coeliacs. Scand J Gastroenterol (1981) 1.05

Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.04

The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. Br J Clin Pharmacol (1982) 1.04

Psychosocial predictors of mortality in the Cardiac Arrhythmia Suppression Trial-1 (CAST-1). Am J Cardiol (1993) 1.04

Can sensory stimulation improve the functional outcome in stroke patients? Neurology (1993) 1.04

Use of the laryngeal mask airway during magnetic resonance imaging. Anaesthesia (1992) 1.03

Maternal inheritance of extrachromosomal DNA in malaria parasites. Mol Biochem Parasitol (1994) 1.03

Cimetidine, but not oxmetidine, penetrates into the cerebrospinal fluid after a single intravenous dose. Br J Clin Pharmacol (1982) 1.02

The effects of cimetidine (Tagamet) on renal function in patients with renal failure. Acta Med Scand (1980) 1.01

Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab (1995) 1.00

A summary index for the assessment of quality of life in angina pectoris. J Clin Epidemiol (1991) 1.00

Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study. Scand J Gastroenterol (1999) 1.00

Studies on duration of a late recovery period after chronic abuse of ethanol. A cross-sectional study of biochemical and psychiatric indicators. Acta Psychiatr Scand (1982) 1.00

Polymyositis and adult coeliac disease. Acta Neurol Scand (1982) 0.99

Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Aliment Pharmacol Ther (2006) 0.98

Short- and long-term treatment with cimetidine in peptic ulcer disease and the pharmacokinetics of cimetidine. Scand J Gastroenterol Suppl (1979) 0.98

Cimetidine or parietal-cell vagotomy in patients with juxtapyloric ulcers. Lancet (1984) 0.98